MAPK3 and renal carcinoma: Moreover, the m6A-suppressed P2RX6 activation could promote renal cancer cells migration and invasion through ATP-induced Ca2 + influx modulating ERK1/2 phosphorylation and MMP9 signaling pathway [29].